Last reviewed · How we verify

cardiac output changes with "phenylephrine"

University Tunis El Manar · FDA-approved active Small molecule

Phenylephrine is an alpha-1 adrenergic agonist that increases peripheral vascular resistance and blood pressure, which can secondarily affect cardiac output through changes in afterload.

Phenylephrine is an alpha-1 adrenergic agonist that increases peripheral vascular resistance and blood pressure, which can secondarily affect cardiac output through changes in afterload. Used for Hypotension (acute management), Shock (vasopressor support).

At a glance

Generic namecardiac output changes with "phenylephrine"
Also known ascardiac output: CO (cm3 / min) = ITV * S * HR. ITV (cm) = integral time velocity is measured by pulsed doppler at the level of the ascending aorta, on apical cut.
SponsorUniversity Tunis El Manar
Drug classAlpha-1 adrenergic agonist
TargetAlpha-1 adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Phenylephrine selectively binds to alpha-1 adrenergic receptors on vascular smooth muscle, causing vasoconstriction and increased systemic vascular resistance. This elevation in afterload can initially increase blood pressure but may decrease cardiac output due to the increased workload on the heart, or maintain it depending on compensatory mechanisms and baseline cardiac function.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results